Accessibility Statement Skip Navigation

Indicators

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

46.96 -0.36 (-0.76%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist

Other Filings

< Previous 1 2 3 4 5 6 7 8 9

...

Form 8-K

Source: SEC/Edgar

May 02, 2019

Source: SEC/Edgar

March 21, 2019

Source: SEC/Edgar

March 21, 2019

Source: SEC/Edgar

February 28, 2019

Form 8-K

Source: SEC/Edgar

February 20, 2019

Source: SEC/Edgar

February 12, 2019

Source: SEC/Edgar

February 10, 2019

Source: SEC/Edgar

February 05, 2019

Source: SEC/Edgar

February 03, 2019

Form 8-K

Source: SEC/Edgar

January 08, 2019

Source: SEC/Edgar

December 19, 2018

Form 8-K

Source: SEC/Edgar

December 12, 2018

Form 8-K

Source: SEC/Edgar

November 25, 2018

Form 8-K

Source: SEC/Edgar

November 05, 2018

Form 8-K

Source: SEC/Edgar

September 09, 2018

Form 8-K

Source: SEC/Edgar

September 04, 2018

Source: SEC/Edgar

August 27, 2018

Source: SEC/Edgar

August 15, 2018

Form 8-K

Source: SEC/Edgar

August 06, 2018

Form 8-K

Source: SEC/Edgar

May 09, 2018

Form S-8

Source: SEC/Edgar

May 09, 2018

Form 8-K

Source: SEC/Edgar

May 01, 2018

Source: SEC/Edgar

April 05, 2018

Form 8-K

Source: SEC/Edgar

April 05, 2018

Source: SEC/Edgar

April 02, 2018

Source: SEC/Edgar

March 21, 2018

Form 8-K

Source: SEC/Edgar

March 21, 2018

Source: SEC/Edgar

March 21, 2018

Form 8-K

Source: SEC/Edgar

February 19, 2018

Source: SEC/Edgar

February 13, 2018

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.